Hematology and Oncology ZSFG

Carling Ursem, MD
UCSF Assistant Clinical Professor of Medicine

Division of Hematology/Oncology, UCSF and
the SFVA Medical Center

Learning Objectives: 

• Describe the epidemiology of cancer and aging at the VA
• Identify the reasons to perform Geriatric Assessment in veterans with cancer
• Identify the components of Geriatric Assessment

Disclosure: Neither the speaker nor the planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Accreditation: The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  

Designation: UCSF designates this live activity for a maximum of 64 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

The above credit is inclusive of all Fiscal year 2022 SFGH Medicine Grand rounds sessions.  You must sign in to Qualtrics to qualify for CME credit.

Zoom Information

http://tiny.ucsf.edu/DOMGrandRounds

Meeting ID: 968 1679 7792
Password: 1001
Call-in: +1 669 900 6833, +1 213 338 8477, +1 669 219 2599

Contact Information
Melody Davenport-McLaughlin
Clinical Operations
[email protected]
 

This presentation will be recorded and is accessible through My Access

https://lecture.ucsf.edu/ets/Catalog/Full/ab21c2921423425398199ec7e0720d6a2

Vinay Prasad, MD, MPH

Vinay Prasad MD MPH is a practicing hematologist-oncologist and Associate Professor in the Department of Epidemiology and Biostatistics at the University of California San Francisco.

Learning Objectives: 

Strategies to keep up with the literature/ How to be a more critical reader of randomzied trials/ Common pitfalls in trials interpretation

Accreditation statement: The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  
Designation Statement: UCSF designates this live activity for a maximum of 64 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
 

Zoom Information
https://ucsf.zoom.us/s/98167104286?pwd=T3NFK2FDTEtqZ09MUzlsSVY4TVBkQT09#success
Meeting ID: 981 6710 4286
Password: 489529
Call-in: +1 669 900 6833, +1 213 338 8477, +1 669 219 2599

Pamela Munster, MD is a professor of medicine at the University of California, San Francisco, where at the Helen Diller Family Comprehensive Cancer Center, she is leader of the Developmental Therapeutics Program, Director of Early Phase Clinical Trials Unit, and Co-Director of the UCSF Center for BRCA Research. In Dr. Munster’s lab, UCSF scientists are exploring new ways to detect, surveil, intercept, and cure BRCA-related cancers. In addition to her laboratory research, she develops novel strategies to treat patients with incurable cancers as an oncologist. Dr. Munster serves on multiple local, national and international committees focused on developing new treatments for cancer, has published over two hundred articles, authored textbooks and is a frequent lecturer. A native of Switzerland, she leads breast cancer awareness campaigns in the United States, United Arab Emirates, and India.

Dr. Munster was diagnosed with a BRCA2 mutation in 2012. There was not an easy place to coordinate her care, and so she set out to create the UCSF Center for BRCA Research in partnership with Alan Ashworth, PhD, FRS. By transcending the doctor-patient perspective, Dr. Munster gives a framework for successful treatment – epitomizing the personal, patient centered care that is a hallmark of the UCSF medical center. Dr. Munster recently authored Twisting Fate, about her experience as an oncologist and a cancer patient.

To access MGR live streams and current semester recordings, please visit ETS here: DOM Medical Grand Rounds.

Objectives:

• Review updates in the management of breast cancer
• Incorporating genomic data in breast cancer management
• New therapies and paradigms in breast cancer management
• Discuss the landscape of breast cancer in San Francisco